The Effectiveness of the Use of the Drug Recombinant Interferon Alfa-2b for the Prevention of Acute Respiratory Infections in Preschool Children

CHILDREN INFECTIONS
doi 10.22627/2072-8107-2019-18-4-25-31
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Journal of Childrens Infections

Related search

Use of Recombinant Α-2b-Interferon in the Treatment of Acute Respiratory Viral Diseases in Children

CHILD`S HEALTH
2016English

On the Issue of Expanding the Indications of the Use of an Immunomodulating Drug in the Treatment and Prevention of Influenza and Acute Respiratory Infections in Young Children

CHILDREN INFECTIONS
2017English

Treatment of Chronic Hepatitis C With Recombinant Interferon Alfa-2b for Nine Months.

Gut
Gastroenterology
1993English

The Expectorant Therapy for Acute Respiratory Infections in Children

CHILD`S HEALTH
2018English

Recombinant Interferon Alpha-2b in the Management of Malignant Pleural Effusions

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
1997English

Argumentation of Acute Respiratory Viral Infections Nonspecific Prevention in Groups of Children

Russian Journal of Infection and Immunity
Infectious DiseasesAllergyImmunology
2016English

Efficiency of Using Herbal Immunomodulating Drug for Non-Specific Prevention of Acute Respiratory Infections

CHILD`S HEALTH
2018English

Prophylactic Zinc Supplementation for Prevention of Acute Respiratory Infections in Infants and Young Children

Indian Pediatrics
Child HealthPediatricsPerinatology
2014English

Cost-Effectiveness Analysis of OM-85 vs Placebo in the Prevention of Acute Respiratory Tract Infections (ARTIs) in Children That Attend Day-Care Centers

Health Economics Review
Health Policy
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy